Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00496951 · ClinicalTrials.gov registry record
Vagal Tone and Neonatal Abstinence Syndrome
A clinical trial, sponsored by Johns Hopkins University.
- Completed
- Registry status
- 65
- Enrollment target
NCT00496951: Completed study, sponsored by Johns Hopkins University.
NCT00496951 is a clinical trial that has completed, run by Johns Hopkins University. The registered enrollment target is 65 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00496951 has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- 65 participants
- Enrollment target
Study Summary
Symptoms of Neonatal Abstinence Syndrome (NAS) can be attributed largely to dysfunction of the autonomic nervous system in opiate exposed neonates. Vagal tone is a readily available measure of autonomic nervous system functioning. NAS is a widely variable disorder with poorly understood pathophysiology; while all opiate exposed infants will exhibit some signs and symptoms of NAS, only approximately ½ have severe enough symptoms to require pharmacologic therapy. This research seeks to determine the relationship between infant vagal tone and NAS severity. The determination of a link between newborn vagal tone and NAS severity could result in the prediction of infants at risk for severe NAS and provide these infants and mothers with intensified services and early treatment, thereby shortening the course of NAS in the infant.
Interventions
- DEVICE Vagal tone assessment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2006-09 |
| Est. Completion | 2008-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00496951
The ClinicalTrials.gov registry entry for NCT00496951 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 65 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Vagal tone assessment is the first listed.
NCT00496951 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00496951 about?
NCT00496951 is a clinical study titled "Vagal Tone and Neonatal Abstinence Syndrome". Symptoms of Neonatal Abstinence Syndrome (NAS) can be attributed largely to dysfunction of the autonomic nervous system in opiate exposed neonates. Vagal tone is a readily available measure of autonomic nervous system functioning. NAS is a widely variable disorder with poorly understood pathophysiol...
What is the current status of trial NCT00496951?
This trial is currently completed. The enrollment target is 65 participants. The study started on 2006-09. Estimated completion is 2008-09.
What interventions are being tested in trial NCT00496951?
The interventions under investigation include: Vagal tone assessment (DEVICE).
Who is sponsoring clinical trial NCT00496951?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.